New Year Address from the CEO

Year 2020 will enter the history books described as unprecedented, remarkable, extraordinary, or once-in-a lifetime challenge for humanity.  All of us suffered from the restrictions introduced to suppress viral transmission. Many of us had loved ones affected or lost to COVID. Scientist lacked opportunities to meet, discuss and debate...

 

Read more

Interview- Meet Our New FAS, Lisa Creary

We are happy to announce that Lisa Creary joined Omixon as a Field Application Scientist effective October, 2020.  In the following mini-interview Lisa talks about her passion, experiences and thoughts on HLA activities. Welcome Lisa! How did you become a scientist? My first experience of science dates back many moons...

 

Read more

Omixon Launches AzureSeq-200 CE IVD Kit For One-step RT-qPCR Detection of SARS-CoV-2 and Announces Exclusive Agreement with SeqOnce Biosciences

As much as Omixon wants to stay focused on the needs of histocompatibility labs, the current coronavirus pandemic calls for innovation in the field of viral detection based on molecular diagnostics. Omixon has used its product development capabilities and collaboration network to develop a truly innovative product addressing an...

 

Read more